A scientist is trying to design a drug to modulate cellular metabolism in the treatment of obesity. Specifically, he is interested in understanding how fats are processed in adipocytes in response to different energy states. His target is a protein within these cells that catalyzes catabolism of an energy source. The products of this reaction are subsequently used in gluconeogenesis or β-oxidation. Which of the following is true of the most likely protein that is being studied by this scientist?

It is stimulated by epinephrine

It is inhibited by acetylcholine

A previously healthy 22-year-old man comes to the physician because of multiple nodules on his hands that first appeared a few months ago. He works as a computer game programmer. His father died of a myocardial infarction at 37 years of age, and his mother has rheumatoid arthritis. A photograph of the lesions is shown. The nodules are firm, mobile, and nontender. Which of the following is the most likely mechanism underlying this patient's skin findings?

Crystallization of monosodium urate

A 1-year-old girl is brought to the pediatrician because of a 6-month history of diarrhea. She has not received recommended well-child examinations. Her stools are foul-smelling and nonbloody. There is no family history of serious illness. She is at the 15th percentile for height and 5th percentile for weight. Physical examination shows abdominal distension. Her serum triglyceride concentration is 5 mg/dL. Genetic analysis shows a mutation in the gene that encodes microsomal triglyceride transfer protein. Which of the following is the most appropriate treatment for this patient's condition?

Restriction of long-chain fatty acids

A 33-year-old man presents with his recent laboratory results. He has no symptoms currently, but he underwent a medical evaluation as a requirement for taking up a new job. His medical history is not significant. His laboratory reports are as follows: Blood hemoglobin 13.7 g/dL Leukocyte count 8,000/mm3 Platelet count 350,000/mm3 Serum creatinine 0.8 mg/dL Serum alanine aminotransferase 16 U/L Serum aspartate aminotransferase 14 U/L Serum cholesterol 450 mg/dL Serum triglyceride 790 mg/dL Serum LDL cholesterol 150 mg/dL Serum HDL cholesterol 55 mg/dL Which of the following findings is most likely to be present on physical examination of this patient?

Palmar xanthomas in flexor creases

Metacarpophalangeal extensor tendon xanthoma

A 14-year-old boy comes to the physician for a follow-up after a blood test showed a serum triglyceride level of 821 mg/dL. Several of his family members have familial hypertriglyceridemia. The patient is prescribed a fibrate medication that increases his risk of gallstone disease. The expected beneficial effect of this drug is most likely due to which of the following actions?

Increased lipoprotein lipase activity

Increased bile acid sequestration

Decreased HMG-CoA reductase activity

Decreased lipolysis in adipose tissue

A 10-month-old boy with a seizure disorder is brought to the physician by his mother because of a 2-day history of vomiting and lethargy. Laboratory studies show a decreased serum glucose concentration with low ketones. Further testing confirms a deficiency in an enzyme involved in fatty acid oxidation. Which of the following enzymes is most likely deficient in this patient?

Glycerol-3-phosphate dehydrogenase

A 35-year-old man comes to the physician because of fatigue and generalized weakness for the past year. He has noticed he has been having fewer bowel movements. He has had pain with defecation and small amounts of blood when wiping. He has not lost weight despite increased efforts to diet and exercise. He has had no fever, throat pain, or difficulty swallowing. His temperature is 36.5°C (97.7°F), pulse is 50/min, blood pressure is 120/90 mm Hg, and BMI is 35 kg/m2. Physical examination shows dry skin and a distended abdomen. There is 1+ pitting edema in the lower extremities. On neurological examination, deep tendon reflexes are 1+. Further evaluation of this patient is most likely to show which of the following findings?

Elevated serum low-density lipoprotein

Decreased plasma homocysteine concentrations

Decreased serum creatine kinase

A 24-year-old man presents for an annual check-up. He is a bodybuilder and tells you he is on a protein-rich diet that only allows for minimal carbohydrate intake. His friend suggests he try exogenous glucagon to help him lose some excess weight before an upcoming competition. Which of the following effects of glucagon is he attempting to exploit?

Increased lipolysis in adipose tissues

Increased glucose utilization by tissues

Decreased blood cholesterol level

Increased hepatic gluconeogenesis

Increased hepatic glycogenolysis

Lipoprotein metabolism for USMLE Step 1: High-Yield Biochemistry Lessons

Lipoprotein Structure - Greasy Little Packets

Lipoprotein Particle Diagram

General Structure: Spherical particles composed of a hydrophobic core and a hydrophilic shell, allowing transport of lipids in aqueous plasma.
- Core: Triglycerides & cholesteryl esters (nonpolar).
- Shell: Apolipoproteins, phospholipids, & free cholesterol (amphipathic).
Apolipoproteins: Key surface proteins that function as enzyme cofactors (e.g., C-II for LPL) and receptor ligands (e.g., B-100 for LDL-R).
Classification (by ↑ density): Chylomicron → VLDL → IDL → LDL → HDL.

⭐ LDL ("Lousy" cholesterol) is the primary transporter of cholesterol to peripheral tissues. Elevated levels are a major risk factor for atherosclerosis.

Exogenous Pathway - The Gut-to-Guts Route

📌 Mnemonic: 'Exogenous' = 'Eats' (dietary fat).

Chylomicrons: Formed in intestines with ApoB-48 to transport dietary TGs/cholesterol.
Maturation: HDL donates ApoC-II (LPL activator) & ApoE (hepatic uptake).
Clearance: LPL releases FFAs to periphery; remnants cleared by liver via ApoE.

Lipoprotein Metabolism: Exogenous and Endogenous Pathways

⭐ Deficiency in LPL or ApoC-II causes Type 1 hyperlipoproteinemia (Familial Chylomicronemia Syndrome), presenting with acute pancreatitis.

Endogenous Pathway - Liver's Delivery Service

Origin: Liver synthesizes VLDL particles, which contain endogenous triglycerides and cholesterol, tagged with ApoB-100.
Metabolism:
- VLDL is released into circulation.
- Lipoprotein Lipase (LPL) on endothelial cells hydrolyzes triglycerides, transforming VLDL → IDL.
- Hepatic Lipase (HL) in the liver removes more triglycerides, converting IDL → LDL.
Destination: LDL delivers cholesterol to peripheral tissues and the liver via LDL-receptor binding (ApoB-100 mediated).

Endogenous Lipoprotein Metabolism: VLDL, IDL, LDL Pathway

⭐ In Familial Hypercholesterolemia, defective LDL receptors (or ApoB-100) prevent LDL uptake, causing markedly elevated plasma LDL and premature cardiovascular disease.

Reverse Transport - The Cleanup Crew

Nascent HDL: Secreted from the liver and intestine, containing ApoA-I. It extracts cholesterol from peripheral tissues.
LCAT: Lecithin-cholesterol acyltransferase, activated by ApoA-I, esterifies cholesterol. This traps it within the HDL core, forming mature HDL.
CETP: Cholesteryl ester transfer protein mediates the transfer of these cholesterol esters to VLDL/IDL in exchange for triglycerides.

⭐ Tangier Disease: A deficiency in the ABCA1 transporter prevents cholesterol loading onto nascent HDL. This leads to very low HDL levels, peripheral neuropathy, and pathognomonic orange-colored tonsils.

Reverse Cholesterol Transport and HDL Metabolism

Dyslipidemias - When Lipids Go Rogue

Familial dyslipidemias are genetic disorders of lipoprotein metabolism. The Fredrickson classification categorizes them based on specific lipoprotein elevations.

Type	Defect	↑ Lipoprotein	Key Clinical Finding
I	LPL / ApoC-II	Chylomicrons	Acute pancreatitis, eruptive xanthomas
IIa	LDL-R	LDL	Tendon xanthomas, premature CAD
IIb	↑ ApoB	LDL, VLDL	Increased risk of CAD
III	ApoE	IDL (Remnants)	Palmar/tuboeruptive xanthomas
IV	↑ VLDL prod.	VLDL	Associated with insulin resistance

High‑Yield Points - ⚡ Biggest Takeaways

Chylomicrons transport dietary triglycerides from the intestine; VLDL transports hepatic triglycerides from the liver.

Lipoprotein lipase (LPL), activated by ApoC-II, degrades triglycerides in chylomicrons and VLDL.

LDL is the primary carrier of cholesterol to peripheral tissues; elevated levels are atherogenic.

HDL facilitates reverse cholesterol transport from the periphery to the liver.

ApoB-100 is the ligand for the LDL receptor; ApoA-I activates LCAT for HDL maturation.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play